Publication | Closed Access

Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus

Metabolic SyndromeDiabetes ManagementHealth SciencesDiabetesPharmacologyPhysiologyType 2PharmacotherapyDiabetes MellitusInsulin DeliveryMedicineChinese Patients